Eli Lilly and Company (LLY)

NYSE: Health Care

Get a 5-page Ratings Report on (LLY) now

$55.90

-0.04 | -0.07%

Today's Range: 55.35 - 56.23

LLY Avg. Daily Volume: 5,136,800

05/17/13 - 4:02 PM ET

Select Your Broker

Need a Broker?

TD Ameritrade

E*TRADE

Scottrade

Fidelity

Insider Trading

Historical Data	Current	1 Mo. Ago	2 Mo. Ago	3 Mo. Ago	4 Mo. Ago	5 Mo. Ago	6 Mo. Ago

Net Insider Transaction	351,491	398,633	420,333	36,651	-7,143	-11,031	-18,156
Shares Bought	398,991	437,633	449,976	51,294	12,500	0	0
Shares Sold	47,500	39,000	29,643	14,643	19,643	11,031	18,156

Institutional Trading

Historical Data	Current	1 Mo. Ago	2 Mo. Ago	3 Mo. Ago	4 Mo. Ago	5 Mo. Ago	6 Mo. Ago

Total Shares Held	831.12M	830.26M	827.45M	838.98M	853.74M	859.57M	844.91M
Shares Bought	60.93M	58.98M	57.63M	56.27M	80.40M	78.06M	76.15M
Shares Sold	54.07M	59.26M	62.27M	62.41M	63.25M	59.69M	52.36M

(LLY) News

AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward
TheStreet.com | 05/16/13 - 01:04 PM EDT
Eli Lilly And Company (LLY): Today's Featured Drugs Winner
TheStreet.com | 05/15/13 - 05:00 PM EDT
4 Stocks Going Ex-Dividend Tomorrow: GIL, ACC, ADM, LLY
TheStreet.com | 05/13/13 - 10:00 AM EDT
Eli Lilly And Stock To Go Ex-dividend Tomorrow (LLY)
TheStreet.com | 05/13/13 - 09:53 AM EDT
Time to Cash In on Actavis
RealMoneyPro.com | 05/13/13 - 09:00 AM EDT
Time to Cash In on Actavis
RealMoney.com | 05/13/13 - 09:00 AM EDT
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint In ...
TheStreet.com | 05/10/13 - 08:00 AM EDT
4 Stocks Pushing The Drugs Industry Downward
TheStreet.com | 05/07/13 - 01:03 PM EDT
Retrospective Analysis Of Linagliptin Data In Sub-populations With Type 2 Dia...
TheStreet.com | 05/06/13 - 06:38 PM EDT
Lilly Announces CEO Dr. John Lechleiter To Undergo Scheduled Surgery
TheStreet.com | 05/06/13 - 04:30 PM EDT
Lilly Declares Second-Quarter 2013 Dividend
TheStreet.com | 05/06/13 - 02:30 PM EDT
It's Pipeline That Matters Most
TheStreet.com | 05/04/13 - 04:30 AM EDT
Cramer: Big Pharma Has Lost Its Way
TheStreet.com | 05/03/13 - 11:49 AM EDT
Boehringer Ingelheim Pharmaceuticals, Inc. And Eli Lilly And Company Launch E...
TheStreet.com | 05/02/13 - 08:00 AM EDT
Cramer's 'Mad Money' Recap: Good Earnings, Bad Market
TheStreet.com | 05/01/13 - 08:09 PM EDT
It's Pipeline That Matters Most
RealMoney.com | 05/01/13 - 12:49 PM EDT
It's Pipeline That Matters Most
RealMoneyPro.com | 05/01/13 - 12:49 PM EDT
Eli Lilly And Company (LLY): Today's Featured Health Care Laggard
TheStreet.com | 04/30/13 - 05:01 PM EDT
Eli Lilly And Company Stock Buy Recommendation Reiterated (LLY)
TheStreet.com | 04/30/13 - 10:00 AM EDT
Lilly Diabetes And Disney Publishing Worldwide Expand Collaboration
TheStreet.com | 04/30/13 - 08:00 AM EDT
Lilly Celebrates National Volunteer Week With Deployment Of Global Service Te...
TheStreet.com | 04/26/13 - 07:00 AM EDT
Cramer's 'Mad Money' Recap: A Lemming Market
TheStreet.com | 04/24/13 - 07:52 PM EDT
Cramer's 6 Stocks in 60 Seconds: JNPR EW HSY PNRA RLGY LLY (Update 1)
TheStreet.com | 04/24/13 - 05:16 PM EDT
National Lemming Day
RealMoney.com | 04/24/13 - 01:16 PM EDT
National Lemming Day
RealMoneyPro.com | 04/24/13 - 01:16 PM EDT
5 Stocks Pulling The Health Care Sector Downward
TheStreet.com | 04/24/13 - 01:03 PM EDT
Lilly Again Named One Of DiversityInc's Top 50 Companies For Diversity
TheStreet.com | 04/24/13 - 11:00 AM EDT
Eli Lilly And Stock Hits New 52-Week High (LLY)
TheStreet.com | 04/23/13 - 10:53 AM EDT
CAT, NFLX to Report in Week Ahead
Street Watch | 04/19/13 - 03:55 PM EDT
Eli Lilly Says Experimental Diabetes Drug Meets Goals
Street Watch | 04/17/13 - 10:43 AM EDT

More (LLY) News

Select the service that is right for you!

COMPARE ALL SERVICES

Action Alerts PLUS

TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:

$2.5+ million portfolio
Large-cap and dividend focus
Intraday trade alerts from Cramer
Weekly roundups

Dividend Stock Advisor

TRY IT FREE

New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:

Diversified model portfolio of dividend stocks
Alerts when market news affect the portfolio
Bi-weekly updates with exact steps to take - BUY, HOLD, SELL

Stocks Under $10

TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:

Model portfolio
Stocks trading below $10
Intraday trade alerts
Weekly roundups

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:

Jim Cramer + 20 Wall Street pros
Intraday commentary & news
Real-time trading forum
Actionable trade ideas

Real Money Pro

TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:

Real Money + Doug Kass + 15 more Wall Street Pros
Intraday commentary & news
Ultra-actionable trading ideas

Options Profits

TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.